In re Quality Systems, Inc. Securities Litigation
|Court:||United States District Court, Central District of California|
|Judge:||Hon. Cormac J. Carney|
|Case Contacts:||Gerald H. Silk, Avi Josefson|
This is a securities fraud class action on behalf of purchasers of Quality Systems, Inc. (“QSI” or the “Company”) common stock during the period from May 26, 2011 through July 25, 2012, inclusive (the “Class Period”), alleging claims pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 against QSI; the Company’s founder and Chairman, Sheldon Razin; its Chief Executive Officer, Steven T. Plochocki; and its Chief Financial Officer, Paul Holt (collectively, “Defendants”).
Lead Plaintiffs Have Settled the Action for $19.5 Million
The Court-appointed Lead Plaintiffs, Arkansas Teacher Retirement System and City of Miami Fire Fighters’ and Police Officers’ Retirement Trust, have reached a settlement of this action for $19,000,000 in cash with Defendants that resolves all claims in the action.
If you are a member of the Class, your rights will be affected and you may be eligible for a payment from the settlement. The Class consists of:
all persons or entities who purchased or otherwise acquired QSI common stock during the period from May 26, 2011 through July 25, 2012, inclusive, and were damaged thereby, except for certain persons and entities who are excluded from the Class by definition (see paragraph 18 of the Notice).
Please read the Notice to fully understand your rights. Copies of the Notice and Claim Form can be found on the Case Documents page. You may also visit the Settlement website, www.QSISecuritiesSettlement.com, for more information about the Settlement.
Following a hearing on November 19, 2018, the Court entered an Order granting Plaintiffs’ motions for final approval of the Settlement and for attorneys’ fees and expenses; entered a Final Judgment approving the Settlement as fair, reasonable and adequate; entered an order approving the Plan of Allocation for the proceeds of the Settlement; and entered an order awarding attorneys’ fees and expenses.
If you are a member of the Class, in order to be potentially eligible to receive a payment under the proposed Settlement, you must submit a Claim Form postmarked no later than December 12, 2018. Payments to eligible claimants will be made only after the completion of all claims processing. Please be patient, as this process will take some time to complete.
IMPORTANT DATES AND DEADLINES
|December 12, 2018||Claim Filing Deadline. Claim Forms must be postmarked no later than December 12, 2018 to be eligible for a payment from the Settlement.|
QSI develops and sells practice management software to medical and dental providers, including software related to scheduling and billing. Throughout the Class Period, QSI portrayed itself as a high-growth company, repeatedly touting its record growth in revenue and earnings, and robust pipeline of business that contained hundreds of millions of dollars of software sales that the Company sought to realize within the next six to eight months. QSI also repeatedly issued bullish annual guidance to investors, stating that it was confident that it would achieve annual growth rates in earnings per share (“EPS”) well in excess of 20%.
Lead Plaintiffs allege that, in truth, Defendants knew and recklessly disregarded that QSI’s growth was materially slowing. Lead Plaintiffs allege that, throughout the Class Period, Defendants were privy to real-time data concerning the revenues and earnings of each of QSI’s operating divisions, and QSI’s guidance was continuously updated based on that real-time data. Accordingly, Lead Plaintiffs contend that Defendants knew and recklessly disregarded that the fiscal 2012 guidance calling for earnings growth of as much as 33% was directly contradicted by the reality of QSI’s performance.
On May 7, 2012, the Company announced that it was experiencing delays in closing sales, which raised investor concerns about the Company’s fiscal 2012 performance. Following this announcement, QSI’s stock price declined 17% over the next two trading days, falling from a closing price of $36.99 on May 6 to a closing price of $30.99 on May 8, on very high volume.
A few days later, on May 10, 2012, QSI revealed that its ability to generate earnings had materially slowed in fiscal 2012. Specifically, QSI announced that it would report EPS of between $1.27 and $1.30 for fiscal 2012 – or as much as 36% below its guidance. Following this announcement, QSI’s stock price immediately declined 6%, falling from $32.09 to $30.12 on May 10, on extremely high volume.
Then, before the market opened on July 26, 2012, Defendants announced that the Company’s EPS had materially declined from the year-ago quarter, and withdrew QSI’s highly favorable fiscal 2013 guidance. That disclosure caused the price of QSI stock to decline from $23.63 per share to $15.95 per share on July 26, 2012.
On April 7, 2014, Lead Plaintiffs filed an Amended Complaint For Violations Of The Federal Securities Laws (“Amended Complaint”). In June 2014, Defendants filed a motion to dismiss the Amended Complaint, which Lead Plaintiffs opposed. In October 2014, the court granted the motion to dismiss. In January 2015, the court denied Lead Plaintiffs’ motion for reconsideration. Following Lead Plaintiffs’ appeal of these decisions, on July 28, 2017, the Ninth Circuit Court of Appeals reversed the district court’s order and remanded for further proceedings.
Following the Court of Appeals’ decision, Lead Plaintiffs and Defendants began formal discovery. After substantial document discovery and settlement negotiations, including before mediation before Gregory P. Lindstrom, Esq., of Phillips ADR, a nationally recognized mediator, the parties reached an agreement to settle all claims in the action for $19 million.
On November 19, 2018, following a hearing, the Court approved the Settlement as fair, reasonable and adequate and approved the Plan of Allocation for the proceeds of the Settlement.
Other Cases of Interest
- Chemours Company
District of Delaware Hannah Ross, Avi Josefson, Michael D. Blatchley, Gregory V. Varallo
- Cardinal Health, Inc.
Southern District of Ohio Avi Josefson, Michael D. Blatchley, Scott R. Foglietta
- EQT Corporation
Western District of Pennsylvania Avi Josefson
- Spectrum Brands Holdings, Inc.
Western District of Wisconsin Avi Josefson, Katherine M. Sinderson, Jai K. Chandrasekhar, Matthew Traylor
- Venator Materials PLC
Southern District of New York Avi Josefson, Michael D. Blatchley, Scott R. Foglietta
- Karyopharm Therapeutics Inc.
District of Massachusetts Avi Josefson, Hannah Ross, Michael D. Blatchley, Scott R. Foglietta
- Quality Systems, Inc.
Central District of California Gerald H. Silk, Avi Josefson
- Alere Inc.
District of Massachusetts Gerald H. Silk, Adam H. Wierzbowski
- Volkswagen AG
Northern District of California Gerald H. Silk, Avi Josefson, James A. Harrod, Jeroen van Kwawegen, Adam Hollander